Ad
related to: news pfizer
Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoPfizer expects adjusted earnings of $2.15 to $2.35 per share and $58.5 billion to $61.5 billion in...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 19 hours agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 4 hours agoThe news comes amid growing concerns about the H5 bird flu, which has shown up on egg farms in 48...
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 6 days agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research report issued on Wednesday ...
Pfizer (NYSE:PFE) Shares Up 2%
ETF DAILY NEWS· 7 days agoPfizer Inc. (NYSE:PFE – Get Free Report)’s share price was up 2% during trading on Wednesday . The stock traded as high as $29.18 and last traded at $29.13. Approximately ...
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend...
Benzinga· 2 days agoArgus Research analyst David Toungdowngraded the stock from Buy to Hold on March 22. This analyst...
Bird Flu Confirmed in Third Farmworker. It’s the First Case With Respiratory Symptoms.
Barrons.com· 5 hours agoThe news of the additional case comes amid preparations for a possible human vaccine for the avian...
Krispy Kreme hires new chief legal officer
Winston-Salem Journal· 7 hours agoKrispy Kreme announced Thursday it has hired Atiba Adams as chief legal officer, effective June 25. Adams was based at the company's Charlotte...
US poised to invest millions in mRNA bird flu vaccine amid H5N1 scare
Daily Telegraph· 9 hours agoIn past influenza pandemics, including the Swine Flu outbreak in 2009, vaccines were often delayed...
Guillain-Barre syndrome ‘more common than expected’ with RSV vaccine in older people, CDC reiterates
The Columbian· 5 hours agoFood and Drug Administration say they’re evaluating any risks, but do not plan to change their...
